The nature of the oligosaccharide chains of the major envelope glycoprotein, gp85, from avian myeloblastosis-associated viruses has been examined for the subgroup A and subgroup B viruses replicated in fibroblasts from the same chicken embryos. Pronase-digested The standard strain of avian myeloblastosis virus (AMV), BAI strain A, contains both a replication-defective virus with in vitro hematopoietic cell transforming activity and nondefective helper viruses of subgroups A and B that are designated myeloblastosis-associated viruses 1 and 2 (MAV-1, subgroup A; MAV-2, subgroup B) (14, 21). MAV-1 and MAV-2 have been shown to induce osteopetrosis, nephroblastoma, and lymphoid leukosis in infected chickens, even though neither virus has in vitro transforming abilities (1, 21, 25). Whereas both of these helper viruses can replicate in chicken embryo fibroblasts (CEF), only the subgroup B virus is able to replicate in macrophages and myeloblasts (21). Only a fraction of the envelope glycoprotein apparently determines the host range and other subgroup-specific properties, since the oligonucleotide maps of genome RNA from MAV-1 and MAV-2 are very similar except for a difference in three of the oligonucleotides from the envelope region (3, 24) .
The nature of the oligosaccharide chains of the major envelope glycoprotein, gp85, from avian myeloblastosis-associated viruses has been examined for the subgroup A and subgroup B viruses replicated in fibroblasts from the same chicken embryos. Pronase-digested glycopeptides from [3H]mannose-or [3H]glucosamine-labeled viruses were analyzed by the combined techniques of gel filtration, endo-p-N-acetylglucosaminidase digestion, and concanavalin A affinity chromatography. The gp85 protein from these two viruses, and also from another subgroup A avian leukosis virus replicated in the same cells, contained a diverse array of asparagine-linked oligosaccharides of the acidic type [(sialic acid±ga-lactose-N-acetylglucosamine)2-4-(mannose)3-N-acetylglucosamine2( ±fucose)-asparagine], hybrid type (sialic acid±galactose-N-acetylglucosamine-(mannose)5,4-N-acetylglucosaminez-asparagine), and neutral type [(mannose)5_-Nacetylglucosamine2-asparagine], with the more highly branched (tri-or tetraantennary or both) acidic-type structures representing the predominant class of oligosaccharide. Minor differences were observed between the gp85 of the subgroup B versus subgroup A viruses.
The standard strain of avian myeloblastosis virus (AMV), BAI strain A, contains both a replication-defective virus with in vitro hematopoietic cell transforming activity and nondefective helper viruses of subgroups A and B that are designated myeloblastosis-associated viruses 1 and 2 (MAV-1, subgroup A; MAV-2, subgroup B) (14, 21) . MAV-1 and MAV-2 have been shown to induce osteopetrosis, nephroblastoma, and lymphoid leukosis in infected chickens, even though neither virus has in vitro transforming abilities (1, 21, 25) . Whereas both of these helper viruses can replicate in chicken embryo fibroblasts (CEF), only the subgroup B virus is able to replicate in macrophages and myeloblasts (21) . Only a fraction of the envelope glycoprotein apparently determines the host range and other subgroup-specific properties, since the oligonucleotide maps of genome RNA from MAV-1 and MAV-2 are very similar except for a difference in three of the oligonucleotides from the envelope region (3, 24) .
A number of characteristics of the major glycoprotein, gp85, of the standard strain of AMV have been determined (19, 20, 23) . (i) the apparent molecular weight from polyacrylamide gel electrophoresis is approximately 80,000; (ii) the carbohydrate content is approximately 40% by weight and consists of N-acetylglucosamine (GlcNAc), galactose (Gal), mannose (Man), sialic acid (NeuNAc), and fucose (in decreasing order of abundance), but not N-acetylgalactosamine; and (iii) the protein exhibits significant charge heterogeneity, with pl values ranging from 4.2 to 5.0. However, the possible presence of both subgroup A and B virus glycoproteins in unknown ratios and the undetermined cellular sources(s) of virus isolated from the sera of infected chickens make the interpretation of these results difficult. The host cell may be especially important in the analysis of the carbohydrate moieties of AMV or MAV-2 glycoproteins: the oligosaccharides were antigenically reactive when derived from virus isolated from sera of infected chickens or AMV-infected myeloblasts in culture, but not when derived from virus grown in CEF (27, 28) . In addition, the host cell-dependent glycosylation of avian retrovirus glycoproteins is altered in transformed versus nontransformed CEF (10, 17) .
The objectives of the present studies were to isolate gp85 from 3H-sugar-labeled MAV-1 and MATERIALS AND METHODS Preparation of radiolabeled virus. CEF of C/E phenotype were prepared from embryonated eggs (Life Sciences Inc., St. Petersburg, Fla.) and grown in tissue culture as described previously (10, 13) . Cultures derived from the same embryos were infected at the third passage with either MAV-1, MAV-2, or RAV-1. The RAV-1 was obtained from Paul Neiman (University of Washington) (29) , and the MAV-1 and MAV-2 were obtained from J. H. Chen (Life Sciences, Inc.). These strains of MAV-1 and MAV-2 were originally isolated in the laboratory of Carlo Moscovici (25) . Virus-infected cells at the eighth passage were grown to confluency in 75-cm2 culture flasks, and radiolabeling was done in Eagle minimum essential medium with one-third the normal concentration of glucose (0.33 mg/ml) and supplemented with 2% fetal bovine serum (K. C. Biologicals) and either 200 ,uCi of [2-3H]mannose (14. 5 Ci/mmol; New England Nuclear Corp.) per ml or 50 ,uCi of [6-3H] glucosamine (38 Ci/ mmol; Amersham Corp.) per ml. After labeling for approximately 24 h at 37°C, the medium was harvested, and fresh medium lacking radioactive sugars, but containing the normal amount of glucose and 2% fetal bovine serum, was added. The cultures were incubated for an additional 24 h at 37°C, and this second medium was also harvested. The two harvests of medium for each virus-infected culture were combined, and radiolabeled virus was purified from clarified medium by ultracentrifugation (13) .
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Analytical gel electrophoresis of samples of purified virus was performed in 10% polyacrylamide slab gels by using the discontinuous buffer system of Laemmli (16) . The major viral glycoprotein species, gp85, was isolated by preparative electrophoresis of virus in 8% polyacrylamide cylindrical gels (7) .
Preparation and gel filtration of pronase-digested glycopeptides. Radiolabeled gp85 was extensively digested with pronase (Calbiochem) (5), and the glycopeptides were desalted on a column of Sephadex G15/ G50 (Pharmacia Fine Chemicals) (11) . Glycopeptides and oligosaccharides were analyzed by gel filtration through columns (120 by 1.5 cm) of Bio-Gel P-4 (minus 400 mesh; Bio-Rad Laboratories) along with unlabeled and "C-labeled gel filtration markers (10, 11, 13) . The elution positions of a series of neutral oligomannosyl cores of known composition [(Man)"GlcNAcj; n = 3 to 9] were used to calibrate the Bio-Gel P-4 columns before the gel filtration of endo-o-N-acetylglucosaminidase digestion products (8, 10 Lectin affinity chromatography. Endoglycosidase Dand H-digested glycopeptides were fractionated on columns of concanavalin A (ConA)-agarose (Sigma Chemical Co.) as recently described in detail elsewhere (9) . Unbound glycopeptides or oligosaccharides (or both) were washed through the columns with 10 mM Tris (pH 7.4) and bound glycopeptides or oligosaccharides were sequentially eluted with the same buffer containing 10, 50, and 100 mM a-methyl mannoside. Peak fractions of unbound or bound and eluted radiolabel were concentrated by lyophilization.
RESULTS
Electrophoretic comparisons of the glycoproteins of MAV-1, MAV-2, and RAV-1. The only major [3H]mannose-labeled protein observed in the sodium dodecyl sulfate-polyacrylamide electrophoretic profiles of virus purified from the growth medium of MAV-1-, MAV-2-, or RAV-1-infected CEF cultures was gp85, the major envelope glycoprotein of avian retroviruses (Fig. 1) . The electrophoretic mobility of MAV-2 gp85 ( Fig. lb) was slightly lower than the mobility of gp85 from the two subgroup A viruses, RAV-1 and MAV-1 ( Fig. la and c) . In addition, MAV-2 gp85 exhibited greater apparent molecular weight heterogeneity than MAV-1 gp85. Differences in the electrophoretic mobility have been reported earlier between gp85 from avian retro- group B gp85 exhibiting a lower mobility than subgroup A gp85 when the viruses were both released from Rous sarcoma virus (RSV)-transformed CEF (6) . Several minor proteins of higher molecular -Il ) weight were detected in both the MAV-1 and MAV-2 samples ( Fig. lb and c previously demonstrated for Prague C RSV (PrC RSV) gp85 (12) .
The size distribution of the endoglycosidaseresistant glycopeptides was similar for all three viruses and was characteristic of the profiles of [3H]mannose-labeled, acidic-type glycopeptides of a transformation-defective (td) derivative of 120
PrC RSV released from nontransformed CEF (10) . In addition, the distribution of radiolabel among the endoglycosidase-resistant glycopeptides (presumably acidic type), hybrid-type ptednfid oligosaccharides, and (Man)5_9GlcNAc1-size pu2r fid neutral-type oligosaccharides for MAV-1 and and H-MAV-2 gp85 was almost identical to the distrinalyzed bution reported earlier for td PrC RSV glycopepdiolabel tides: 53% acidic, 9% hybrid, and 38% neutral elution for MAV-1 (Fig. 2A) ; 56% acidic, 10% hybrid, ee solid and 34% neutral for MAV-2 (Fig. 2B) d The larger oligomannosyl core structures (containing seven to nine mannoses) are more tightly bound to ConA-agarose and are only eluted at higher concentrations of a-methyl mannoside than required to elute smaller oligomannosyl core structures (containing three, five, or six mannoses) (9).
RSV (10) . The fraction of radiolabel in endoglycosidase-resistant glycopeptides was slightly increased for the RAV-1 gp85 sample (Fig. 2C ): 64% acidic, 8% hybrid, and 28% neutral. Krantz et al. (15) have previously reported that gp85 from RAV-1 replicated in RSV-transformed CEF has both acidic-and neutral-type asparaginyl oligosaccharides in a ratio of approximately 3:1.
Minor amounts of radiolabeled gp37 were obtained from the preparative polyacrylamide gel electrophoresis of [3H]mannose-labeled MAV-2 and RAV-1, and the pronase-digested glycopeptides from these proteins were analyzed in the same manner (data not shown). The minor envelope glycoprotein species from both viruses was apparently enriched for acidic-type oligosaccharides, with relatively less hybridand neutral-type oligosaccharides compared with gp85 from the same viruses. Analysis of the oligosaccharide components of gp37 was difficult because: (i) radiolabel in gp37 was recovered in very low amounts compared with gp85 (Fig. 1) The profile of radiolabel that was unbound to a column of ConA-agarose versus bound and eluted with a-methyl mannoside is shown in Fig.  3 for the endoglycosidase D-and H-digested glycopeptides from [3H]mannose-labeled MAV-2 gp85. Approximately 90% of the radiolabel applied to the column was recovered in fractions 1 through 32, and similar profiles and recoveries of radiolabel were obtained with the MAV-1 and RAV-1 gp85 samples (data not shown).
The gel filtration patterns of radiolabel in the ConA-unbound versus bound and 10 mM amethyl mannoside-eluted fractions are displayed in Fig. 4 for the endoglycosidase-digested glycopeptides of all three viruses. The larger average size of the ConA-unbound and endoglycosidaseresistant glycopeptides (Fig. 4) compared with the ConA-bound, eluted glycopeptides (fractions 45 through 60, Fig. 4) Fig. 2B was fractionated on a column of ConA-agarose, and 0.1-ml samples of each 1.0-ml fraction were assayed for radioactivity. Bound radiolabel was eluted with increasing concentrations of a-methyl mannoside as indicated by the dotted vertical arrows (10 mM for fractions 9 through 16; 50 mM for fractions 17 through 24; 100 mM for fractions 25 through 32). Peak tubes of unbound material or material that was bound and subsequently eluted with a-methyl mannoside were pooled for further gel filtration analysis (Fig. 4B) , as indicated by the bracketed arrows.
tively more of the lower-molecular-weight, ConA-unbound glycopeptides (fractions 50 through 60, Fig. 4A and C) than the MAV-2 gp85 glycopeptides (Fig. 4B) . The apparent ratio of tri-or tetraantennary (or both) acidic-type glycopeptides to diantennary acidic-type glycopeptides was also different between the glycopeptides of MAV-2 gp85 and the glycopeptides of MAV-1 and RAV-1 gp85: the ratio of radiolabel in ConA-unbound versus ConA-bound, eluted glycopeptides (fractions 37 through 62, Fig. 4 ) was 1.8:1.0 for MAV-2 gp85, 3.4:1.0 for MAV-1 gp85, and 3.1:10 for RAV-1 gp85. Much of the size heterogeneity in these endoglycosidase-resistant glycopeptides was apparently due to sialic acid heterogeneity, since removal of terminal sialic acid by hydrolysis with 0.1 N H2SO4 at 80°C for 30 min (5) shifted most of the glycopeptides to later eluting fractions and reduced the size heterogeneity (data not shown).
The endoglycosidase-released oligosaccharides that were recovered in the 10 mM a-methyl mannoside-eluted fractions from the ConA-agarose columns (fractions 62 through 90, gp85 after fractionation by ConA-agarose chromatography. The conditions of gel filtration were identical to those described in Fig. 2 . The endoglycosidase D-and H-digested glycopeptides that were unbound to the lectin affinity column (0; corresponding to fractions 1 through 4 in Fig. 3 for the MAV-2 sample) and the glycopeptides or oligosaccharides that were eluted with 10 mM a-methyl mannoside (0; corresponding to fractions 10 through 16 in Fig. 3) were separately analyzed on the same column, and the proffles were superimposed. (A) MAV-1 gp85 glycopeptides; (B) MAV-2 gp85 glycopeptides; (C) RAV-1 gp85 glycopeptides.
from PrC RSV glycoproteins elute in the position of (Man)8gGlcNAc1-size oligosaccharides (12) , the radiolabel in these (Man)89GlcNAc1-size oligosaccharides most likely represented asialo-hybrid oligosaccharides [Gal-GlcNAc-(Man)5GlcNAcl]. In addition, minor peaks were observed in the ConA-unbound fraction (fractions 66 through 69 and 76 through 79, Fig. 4 ) eluting just after the peaks of the hybrid-type and presumed asialo-hybrid oligosaccharides from the ConA-bound and eluted fraction. These ConA-unbound structures were consistent with the minor species of hybrid-type oligosaccharides containing a four-mannose core ( Table 1) that were previously described for PrC RSV glycoproteins (9, 12) . The radiolabel that was eluted from the ConA-agarose columns with 50 and 100 mM a-methyl mannoside (fractions 18 Table 1 ). The collections of oligosaccharides from MAV-1 and MAV-2 gp85 were similar to each other and also similar to that acquired by gp85 of a typical subgroup A avian leukosis virus (RAV-1) replicated in equivalent CEF and to the previously described glycopeptides from a nontransforming derivative of PrC RSV (10) .
The dramatic difference in gel filtration profiles between the [3H]mannose-labeled glycopeptides ( Fig. 2 and 4 ) and the [3H]glucosaminelabeled glycopeptides (Fig. 5) (23) .
In addition to an apparent molecular weight difference between gp85 of MAV-2 and gp85 of MAV-1 and RAV-1, several differences in the glycopeptides were observed: the ratio of ConAunbound glycopeptides (presumably tri-or tetraantennary [or both] acidic type) versus ConAbound glycopeptides (presumably diantennary acidic type) was higher for MAV-1 and RAV-1 gp85 than for MAV-2 gp85, and the ConAunbound glycopeptides exhibited a more heterogeneous size distribution for gp85 from the subgroup A viruses. These studies suggested that the more highly branched acidic-type structures [(NeuNAc ± Gal-GlcNAc)>2(Man)3GlcNAc2-(±fucose)-AsN] were the predominant class of asparagine-linked oligosaccharides in the glycoproteins from all three viruses. The differences in the oligosaccharide compositions of MAV-1 gp85 and MAV-2 were less than the differences we have previously observed in the glycopeptides of PrC RSV released from transformed versus nontransformed CEF (10). Lai and Duesberg (17) had concluded from earlier studies of subgroup A, C, and D avian retroviruses that strain-or subgroup-specific differences in the size distribution of glycopeptides were minor compared with differences in the same subgroup virus from transformed versus nontransformed cells. More detailed analysis of the envelope glycoproteins of avian retroviruses will be necessary to determine possible differences in the number of oligosaccharide chains per glycoprotein molecule or the distribution of various types of asparagine-linked oligosaccharides along the polypeptide chain for different viral strains.
Because of the reported antigenicity of the oligosaccharide moieties of MAV-2 gp85 when the virus is replicated in AMV-transformed myeloblasts (but not from virus replicated in CEF) (27, 28) , it will be of particular interest to obtain
[3H]mannose-and [ H]glucosamine-labeled virus gp85 from AMV-transformed nonproducer myeloblasts that have been superinfected with MAV-2. The analysis of these radiolabeled glycopeptides in comparison with the present results might reveal compositional or structural alterations in the oligosaccharides that could account for the unusual antigenic properties, such as the possible presence of erythroglycan structures [repeating units of Gal(p1,4)-GlcNAc(,13,3)] in acidic-type asparaginyl oligosaccharides (18, 26) .
